Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

proteinuria

  • You have access
    Impact of Chronic Kidney Disease on End-stage Renal Disease After Treatment for Localized Renal Cell Carcinoma
    SHUNTA HORI, TOMONORI NAKAHAMA, MITSURU TOMIZAWA, KUNIAKI INOUE, KENTA ONISHI, YOSUKE MORIZAWA, DAISUKE GOTOH, YASUSHI NAKAI, MAKITO MIYAKE, TATSUO YONEDA, NOBUMICHI TANAKA and KIYOHIDE FUJIMOTO
    Anticancer Research January 2026, 46 (1) 503-514; DOI: https://doi.org/10.21873/anticanres.17964
  • Open Access
    Efficacy and Safety of Anti-angiogenic Agents for Cancer Patients With Proteinuria or a History of Proteinuria: A Systematic Review
    TAIGO KATO, SHIMON KURASAWA, KENTARO TAKEZAWA, YUTAKA FUJIWARA, YOSHINARI YASUDA and YUICHI ANDO
    Anticancer Research March 2024, 44 (3) 889-894; DOI: https://doi.org/10.21873/anticanres.16882
  • Open Access
    Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
    SATOSHI FUKUDA, YUSUKE NIISATO, MIKI TSUJI, SOMA FUKUDA, YUYA HAGIWARA, TSUBASA ONODA, HIROSUMI SUZUKI, YOSHITAKA TANGE, TAKESHI YAMADA, YOSHIYUKI YAMAMOTO and TOSHIKAZU MORIWAKI
    Anticancer Research May 2023, 43 (5) 2085-2090; DOI: https://doi.org/10.21873/anticanres.16369
  • You have access
    Lack of Association of Proteinuria and Clinical Outcome in Patients Treated with Bevacizumab for Metastatic Colorectal Cancer
    SATORU IWASA, TAKAKO EGUCHI NAKAJIMA, KENGO NAGASHIMA, YOSHITAKA HONMA, KEN KATO, TETSUYA HAMAGUCHI, YASUHIDE YAMADA and YASUHIRO SHIMADA
    Anticancer Research January 2013, 33 (1) 309-316;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire